Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atossa Genetics Inc (ATOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,724
  • Shares Outstanding, K 5,650
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,120 K
  • 36-Month Beta 3.66
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.56
  • Number of Estimates 1
  • High Estimate -0.56
  • Low Estimate -0.56
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.12 +9.82%
on 11/28/18
1.85 -33.51%
on 12/03/18
+0.02 (+1.65%)
since 11/14/18
3-Month
1.12 +9.82%
on 11/28/18
1.96 -37.24%
on 09/27/18
-0.40 (-24.54%)
since 09/14/18
52-Week
1.12 +9.82%
on 11/28/18
10.68 -88.48%
on 02/01/18
-2.71 (-68.75%)
since 12/14/17

Most Recent Stories

More News
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 22.21 (-4.35%)
NGVC : 17.96 (+0.34%)
STC : 41.17 (-0.58%)
ATUS : 17.67 (-0.56%)
RBA : 32.13 (-0.77%)
MHK : 116.98 (-1.03%)
NVCR : 35.66 (+1.02%)
CVSI : 4.8100 (+2.01%)
AC : 34.54 (+1.32%)
BSX : 35.80 (-3.19%)
HON : 136.44 (-1.71%)
POTND : 0.0200 (+32.45%)
PRTT : 1.7000 (+17.24%)
TARSD : 0.2033 (-1.64%)
NKE : 72.53 (-0.55%)
ROIC : 17.68 (+0.63%)
DGX : 85.48 (-3.24%)
EIX : 59.64 (+0.18%)
GARLF : 0.0800 (-3.03%)
MRNA : 18.32 (-2.35%)
MSPC : 0.0002 (unch)
RYAAY : 72.60 (-1.28%)
BA : 318.75 (-2.06%)
BDC : 42.93 (-3.40%)
BC : 46.58 (-1.25%)
OXFD : 13.93 (-2.99%)
NDAQ : 86.54 (-0.55%)
TTOO : 3.92 (+0.77%)
DMAC : 3.54 (+4.12%)
CMCM : 6.92 (+3.75%)
ALGN : 215.57 (-0.76%)
ABM : 25.90 (-1.56%)
RTN : 169.85 (-1.50%)
IESC : 16.13 (-1.29%)
KIDS : 32.96 (+5.04%)
CYL.VN : 0.145 (-9.38%)
FLIR : 43.12 (-1.78%)
NETC.CN : 0.105 (unch)
SLCA : 11.31 (-1.14%)
BANX : 20.20 (-0.49%)
APOG : 31.95 (-1.39%)
RBBN : 5.37 (-1.83%)
SPLIF : 0.1450 (+0.55%)
SO : 47.33 (-0.46%)
SNWV : 0.3049 (+1.63%)
ACB : 5.86 (+2.63%)
CE : 86.69 (-1.28%)
QILFF : 0.1992 (-29.03%)
QILFD : 0.2331 (-29.98%)
MANH : 45.80 (-1.48%)
MKL : 1,048.58 (-1.19%)
HAL : 29.00 (-3.04%)
LZB : 25.73 (-1.98%)
INTC : 47.86 (-0.89%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,591.91 (-4.01%)
ACHC : 28.93 (-6.86%)
TX : 28.33 (-1.22%)
SRPT : 119.52 (-2.05%)
JOUT : 61.75 (+2.07%)
CCAN : 0.2000 (-5.88%)
OBMP : 0.0115 (+0.88%)
ELY : 16.63 (+0.91%)
DY : 53.92 (-4.24%)
HIPH : 0.0330 (-9.84%)
POTN : 0.1433 (-9.30%)
JWN : 48.61 (-0.74%)
SYF : 24.10 (-0.33%)
AQUA : 9.77 (-2.59%)
NWVCF : 0.9457 (+2.02%)
USYNF : 3.1500 (+5.77%)
EMR : 60.44 (-0.48%)
BXE : 0.56 (-4.27%)
HSY : 107.87 (-1.95%)
EW : 160.13 (-2.32%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.52 (-3.70%)
PSX : 86.83 (-2.25%)
MVIS : 0.56 (unch)
PCI : 21.84 (-2.54%)
PCN : 14.94 (-1.45%)
AVT : 38.76 (-1.47%)
MGNX : 13.69 (-7.25%)
ICBK : 20.44 (-0.78%)
DLR : 114.32 (-0.90%)
RHI : 57.76 (-1.08%)
YVR : 3.07 (+3.72%)
PTY : 15.03 (-1.89%)
PDI : 29.95 (-3.11%)
TNXP : 2.81 (+2.93%)
GBT : 42.24 (-0.87%)
QI.VN : 0.290 (-27.50%)
TSRO : 73.69 (-1.07%)
RHP : 71.36 (-1.76%)
NKTR : 36.51 (-3.92%)
GOOG : 1,042.10 (-1.86%)
JBLU : 16.83 (-2.55%)
IGC : 2.49 (unch)
WBT : 12.26 (-1.05%)
WRY.VN : 0.005 (-66.67%)
SAPIF : 31.0080 (+1.77%)
WSO : 147.43 (-1.44%)
LMT : 287.70 (-1.55%)
CMCSA : 36.34 (-1.14%)
HSDT : 9.93 (-0.60%)
GWRE : 82.80 (-1.83%)
CLGX : 36.33 (-1.76%)
FNSR : 21.75 (-1.76%)
SONS : 7.83 (+2.76%)
DEWM : 0.0021 (+5.00%)
SLG : 89.28 (-0.66%)
UPS : 98.66 (-2.10%)
PFN : 9.44 (-1.87%)
KMB : 117.42 (-0.83%)
ANZ.VN : 0.055 (unch)
TAOP : 1.04 (-3.70%)
NSU : 4.38 (-2.01%)
CBDS : 3.5900 (-11.58%)
CTXS : 109.14 (-1.02%)
PCOM : 10.13 (-3.80%)
HTHT : 29.90 (-2.54%)
MAN : 68.38 (-1.38%)
CNK : 40.29 (-0.44%)
AMAT : 32.65 (-3.14%)
FMCC : 1.1300 (unch)
MRK : 76.48 (-3.20%)
ATOS : 1.23 (+3.36%)
WTCRF : 0.0187 (+16.87%)
MLRKF : 0.0712 (+0.14%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 51.35 (-5.47%)
COOL : 17.33 (-0.69%)
SAVE : 59.01 (-2.72%)
PCRX : 45.26 (-1.18%)
RNLSY : 12.4800 (-2.92%)
COL : 141.04 (-0.42%)
COR : 96.90 (-0.71%)
IDXG : 1.02 (+2.00%)
MCD : 183.29 (-1.68%)
ETST : 0.8910 (+11.37%)
QNIIF : 0.7811 (-2.06%)
PII : 79.35 (-0.94%)
AMRS : 4.09 (-2.85%)
SON : 56.00 (-0.16%)
MCK : 116.66 (-5.05%)
APHA : 5.60 (+7.07%)
MCO : 145.52 (-2.30%)
GSKY : 8.66 (-3.24%)
LH : 137.41 (-1.65%)
SAP.TO : 40.85 (-0.49%)
ODFL : 123.43 (-2.44%)
NEU : 394.11 (-0.06%)
ORTX : 14.56 (-2.93%)
BXE.TO : 0.72 (-6.49%)
GWPRF : 10.0500 (+0.23%)
PZN : 9.56 (+1.16%)
RBX.VN : 0.085 (+13.33%)
RNG : 82.47 (-3.17%)
SPG : 182.66 (-0.76%)
TRVN : 0.58 (-4.92%)
AMC : 14.51 (-2.36%)
UTX : 118.80 (-0.38%)
AMD : 19.90 (+0.20%)
NDLS : 6.95 (-5.44%)
MPWR : 118.62 (-2.17%)
KGKG : 0.0990 (+9.88%)
FRO-UN.VN : 0.530 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 18.18 (-1.89%)
IQST : 1.2000 (+18.81%)
ASPS : 21.46 (-3.16%)
HMNY : 0.02 (unch)
ROP : 273.84 (-2.62%)
GOVB : 14.2000 (-8.09%)
PKO : 24.72 (-3.36%)
MYGN : 31.15 (-0.32%)
CRL : 124.96 (-2.31%)
GLPH : 0.0300 (-31.82%)
BXXRF : 0.0200 (unch)
ADTN : 11.52 (-2.29%)
GRNH : 0.0207 (-8.00%)
NS : 24.08 (-1.27%)
LTS : 2.58 (-4.09%)
INT : 22.38 (-2.82%)
INPX : 3.17 (-2.91%)
GSPT : 0.1200 (unch)
MRO.VN : 0.080 (-11.11%)
COST : 207.06 (-8.59%)
EFX : 97.18 (+0.06%)
BMRN : 93.11 (-0.83%)
SPGI : 166.62 (-1.72%)
IGCC : 0.6410 (-2.88%)
PYPL : 85.92 (-1.87%)
LHSIF : 0.7500 (-1.26%)
TDY : 205.31 (+0.59%)
AZPN : 83.19 (-1.35%)
ENW.VN : 1.250 (+1.63%)
DMA.VN : 4.700 (+3.30%)
SNAP : 5.92 (+1.02%)
KSU : 96.67 (-0.49%)
MERC : 11.37 (+1.16%)
DVA : 58.02 (-2.32%)
UNI.VN : 4.200 (-0.94%)
MGI : 1.88 (-1.05%)
IGAP : 0.1500 (+7.14%)
FIT : 4.90 (+2.30%)
RAD : 0.89 (-1.54%)
LDSR : 0.0033 (-2.94%)
CYLYF : 0.1100 (-8.33%)
PMX : 11.05 (-2.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 27.62 (-0.29%)
Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.?

InvestorsObserver issues critical PriceWatch Alerts for ATOS, CRON, NBEV, TSRO, and XXII.

NBEV : 5.94 (+0.85%)
XXII : 2.59 (-2.63%)
ATOS : 1.23 (+3.36%)
TSRO : 73.69 (-1.07%)
Explosion of Latest Clinical Studies and Results Reinvigorating Immunotherapy Market

Leaders in the oncology industry are working relentlessly to develop a wide variety of treatments and applications for cancer. Recent data published from clinical trial results of innovative immunotherapy...

CLVS : 20.76 (-4.02%)
ATOS : 1.23 (+3.36%)
TSRO : 73.69 (-1.07%)
VNDA : 26.24 (+0.34%)
GSK : 37.61 (-0.87%)
MBRX : 1.26 (unch)
Atossa Genetics Announces FDA Approval of Endoxifen for "Expanded Access" as Preoperative Systemic Endocrine Therapy for a U.S. Breast Cancer Patient

Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced that...

ATOS : 1.23 (+3.36%)
Atossa Genetics Announces Third Quarter 2018 Financial Results And Provides Company Update

Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced third...

ATOS : 1.23 (+3.36%)
Report: Developing Opportunities within Crocs, NetApp, Gannett Co., Atossa Genetics, Omega Flex, and Lithia Motors -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Crocs, Inc. (NASDAQ:CROX),...

NTAP : 61.43 (-2.07%)
CROX : 25.39 (-0.04%)
OFLX : 53.53 (-0.54%)
ATOS : 1.23 (+3.36%)
GCI : 9.86 (-2.28%)
LAD : 69.15 (-0.37%)
Atossa Genetics Announces Preliminary Results from Male Phase 1 Study of Topical Endoxifen

***All Objectives Successfully Met***

ATOS : 1.23 (+3.36%)
Atossa Genetics to Host Conference Call to Announce Preliminary Results from Male Phase 1 Study of Topical Endoxifen Thursday, September 13, 2018 at 10 am EDT

Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, will host a conference call...

ATOS : 1.23 (+3.36%)
Atossa Genetics Receives Positive Interim Safety Review from Independent Safety Committee in Phase 1 Topical Endoxifen Dose Escalation Study in Men

Atossa Genetics Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions,...

ATOS : 1.23 (+3.36%)
Atossa Genetics Supports National Women's Health Week Lead by U.S. Department of Health and Human Services' Office on Women's Health

Atossa Genetics Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions,...

ATOS : 1.23 (+3.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ATOS with:

Business Summary

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting...

See More

Key Turning Points

2nd Resistance Point 1.31
1st Resistance Point 1.27
Last Price 1.23
1st Support Level 1.17
2nd Support Level 1.11

See More

52-Week High 10.68
Fibonacci 61.8% 7.03
Fibonacci 50% 5.90
Fibonacci 38.2% 4.77
Last Price 1.23
52-Week Low 1.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar